The ratio of the active progesterone receptor B isoform is higher in the ampullary region of the oviduct. Purpose : To examine mRNA expression of progesterone receptor isoforms AB and B in oviduct mucosal tissue during the ovulatory cycle and in the different functional regions of the human oviduct. Methods : The mucosal layer was isolated from human oviduct tissue and semi-quantitative RT-PCR for progesterone isoforms AB and B was performed. The RT-PCR results were verified by immunohistochemistry. Results : The isthmic region showed no mRNA expression of either progesterone receptor isoform while the relative ratio of the B isoform was significantly higher in the ampullary region compared to the fimbrial region. There was a significant increase in the ratio of PRB to PRAB in the ampullary region compared to the fimbrial region in all samples. Conclusions : We found an increase in the relative abundance of the progesterone receptor B isoform in the ampullary region which is the site of fertilization and early embryo cleavage. Our results indicate that progesterone responsive genes are more likely to be activated in the ampullary region of the oviduct due to the difference in PRAB to PRB ratio. Providing support for the hypothesis that progesterone may play a specific role in providing an appropriate environment for sperm capacitation, fertilization and early embryo cleavage.
INTRODUCTION
One of the functions of the oviduct is to provide a suitable environment for oocyte fertilization and early embryo development. However, while P receptors have been identified in the human oviduct, little is known about P receptor regulation. In other P target tissues, two isoforms of P receptors have been identified, isoform AB (PRAB) and B (PRB). Sun et al. (1) demonstrated the presence of the PRB isoform in the human oviduct as well as the endometrium during the peri-ovulatory phase. There are no data on the regulation of PRAB and PRB during the ovulatory cycle.
The progesterone receptor is a nuclear receptor that regulates a number of physiological and morphological processes in response to ligand binding. A single gene codes for the PRAB and PRB isoforms that are translated from individual messenger RNA (mRNA) species. These are under the control of different promoters (2) . The transcription of both isoforms is indirectly stimulated by estradiol via the estrogen receptor. The B isoform contains an additional 164 amino acids at the N-terminal that are absent in the A isoform (3) . Therefore, while it is not possible to distinguish the A isoform, it is possible to do this for the B isoform.
The relative expression of PRAB and PRB may determine the tissue response to circulating P (4). The PRAB and PRB isoforms lead to differential gene regulation (5) and interact with each other following receptor binding.
This study examines the mRNA expression of the two P receptor isoforms in oviduct mucosal cells during the ovulatory cycle. The expression will also be assessed in samples taken in early pregnancy, the postpartum period and from postmenopausal subjects. This study also examines the mRNA expression of the two P receptor isoforms in oviduct mucosal cells from the three different functional regions of the oviduct.
MATERIALS AND METHODS

Collection of Oviduct Tissue
Oviduct tissue (N = 20) was obtained from women who were undergoing either a laparoscopy for tubal sterilization or a hysterectomy for a benign uterine condition. The stage of the cycle was determined by the date of commencement of the last menstrual period and was confirmed by appropriate serum concentrations of luteinizing hormone (LH), progesterone (P) and estradiol (E 2 ).
Excised oviduct tissue was immediately placed in 20 mL of Hepes buffered Quinn's Human Tubal Fluid (Irvine Scientific, Santa Ana, CA, USA). This medium was used for all tissue manipulation. The oviduct was rinsed to minimize blood cell contamination. The lumen of the oviduct was exposed by incising along the anti-mesenteric border and the mucosal folds were dissected off macroscopically. The samples were taken from the fimbrial, ampullary and isthmic regions of the oviduct. Only two of the investigators performed the tissue dissection and the technique was closely monitored to ensure accurate replication.
Semi-quantitative RT-PCR Analysis
mRNA was extracted from the oviduct mucosal tissue using the Oligotex direct mRNA kit (Qiagen, Hilden, Germany). All mRNA samples were treated with 1 U of DNAse (Boehringer Mannheim/ Hoffman-La Roche, Basel, Switzerland). The DNAse was inactivated by incubating for 5 min at 90
• C. 100 ng of mRNA was used for cDNA synthesis with Multiscribe reverse transcriptase (PE Biosystems, Foster City CA, USA). All the resultant cDNA was then used for PCR with Amplitaq Gold DNA polymerase (PE Biosystems, Foster City CA, USA). Each PCR cycle consisted of denaturation at 94
• C for 1 min, annealing at 55
• C for 1 min and extension at 72
• C for 1 min. Thirty cycles were performed, followed by a final extension at 72
• C for 4 min. The RT-PCR assay was validated by establishing that the coamplified product for the (experimental) PRAB or PRB and (internal standard) β-actin primer sets were linear and parallel with increasing amounts of start cDNA and the cycle number and primer concentrations were optimized in the exponentially increasing phase of the detectable product.
Forward and reverse primers specific to PRAB isoform were derived from Kumar et al. (6) . The sequences of the primers were: forward-ACA GAA TTC ATG ACT GAG CTG AAG GCA AAG GGT reverse-ACA AGA TCT CAA ACA GGC ACC AAG AGC TGC TGA (Mwgag Biotech, Ebersberg, Germany). Forward and reverse primers specific to PRB isoform were derived from Kumar et al. (6) . The sequences of the primers were: forward-ACA GAA TTC ATG ACT GAG CTG AAG GCA AAG GGT reverse-ACA AGA TCT CAA ACA GGC ACC AAG AGC TGC TGA (Mwgag Biotech, Ebersberg Germany). β-actin was co-amplified with PRAB or PRB to provide a semi-quantitative internal control for RNA quantity and PCR reaction efficiency. β-actin is commonly used as a standard when comparing samples under different hormonal conditions, as it is constitutively expressed (7). Forward and reverse primers specific to β-actin were derived from published primer sequences (7) . The sequences of the β-actin primers were: forward-ATC GTG GGG CGC CCC AGG CAC and reverse-CTC CTT AAT GTC ACG CAC GAT TTC (Mwgag Biotech, Ebersberg, Germany).
Twenty percent of each PCR reaction was separated by gel electrophoresis on a 2% agarose gel with 0.5 µg/mL ethidium bromide in TBE buffer. The separated PCR products were visualized under Ultra Violet illumination. A video camera sent the UV illuminated gel image to a computer where the software package Gel Doc enabled an image of the gel to be recorded. The integrated optical density (IOD) was determined for each PCR product by the image analyzer, Gel Doc System. The IOD ratio between the PCR amplified PRAB or PRB product with its simultaneously amplified control, β-actin was obtained for each sample.
Statistics
The nonparametric Wilcoxon sign test was used to determine whether significant differences were present between the ratio of and PRAB or PRB mRNA expression in different regions of the oviduct. A probability value was considered significant when P < 0.05.
Immunohistochemistry
Seventy tissue sections from the 20 oviducts consisting of fimbrial, ampullary and isthmic regions were analyzed for the presence of PRAB or PRB by specific immunohistochemical staining. Tissue sections fixed on glass slides were dewaxed in graded xylenes, rehydrated through graded alcohols and washed in phosphate buffered saline (PBS).
Sections were stained for PRAB or PRB with mouse monoclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The secondary antibody and chromogenic substrate addition was performed using the DAKO Catalyzed Signal Amplification System reagents and protocol (Dako, Glostrup, Denmark). Negative controls were performed by omitting addition of primary antibody. Staining was detected under light microscopy.
RESULTS
Three samples were collected in the early follicular phase, three from the mid-follicular phase, three from the late follicular phase, three from the early luteal phase and two from the late luteal phase.
Two samples were collected during early pregnancy (tubal ligation following first trimester termination of pregnancy), two samples were collected in the postpartum period and two were collected from postmenopausal women.
A PCR product of the appropriate size was obtained from both the PRAB and PRB PCR primers in samples collected from the mid and late follicular phase but not in samples collected from the early follicular phase or from the luteal phase (Fig. 1a and  b) . One sample in the late luteal phase showed weak expression of PRAB but all other luteal phase samples showed no expression. Samples collected during early pregnancy showed high expression of both PRAB and PRB while samples from the postpartum period and from menopausal women were negative for both.
Ratio of PRAB: PRB mRNA Expression in the Follicular Phase
There was no significant difference between the mRNA expression of PRAB in the fimbrial compared to the ampullary region (Fig. 3b and c) . However, there was significantly higher PRB expression in the ampullary compared to fimbrial region, where P<0.0005 (Fig. 2) .
Localization of PRAB and PRB in the Three Functional Regions of the Oviduct by Immunohistochemistry in Samples Obtained in the Follicular Phase
Strong and specific cytoplasmic and nuclear PRAB and PRB staining was observed in the mucosal epithelial cells and more intense staining for both was observed in the smooth muscle cells in samples from the fimbrial region ( Fig. 3b and e) and in samples from the ampullary region ( Fig. 3c  and f) . The two proteins co-localized in the same cell types. Despite no RT-PCR product being detectable in isthmic samples, faint staining of PRAB and PRB was observed in some mucosal epithelial cells, with a much stronger staining of both in the smooth muscle cells (Fig. 3d and g ).
DISCUSSION
The results of this study demonstrate that peak expression of both PRAB and PRB occurs during the late follicular phase in mucosal epithelial cells. This temporal regulation may indicate a role in the early events of reproduction. This study focused on the regulation of PRAB and PRB in the mucosal cells as these are the cells that interact directly with gametes and early embryos. The results of the immunohistochemistry show that regulation of the P receptor isoforms in the smooth muscle layers of the oviduct may be under different control. This may reflect the different function of the muscle layer for gamete and embryo transport.
Both PRAB and PRB isoforms were strongly expressed in the fimbrial and ampullary regions but not in the isthmic region. This may reflect the function of the fimbrial and ampullary regions to maintain an environment suitable for supporting gamete and embryo survival and growth as the gametes and embryos traverse these regions slowly compared to the reported rapid decent of the embryo through the isthmic region (8) .
Both PR isoforms were expressed in the fimbrial and ampullary regions. In these samples there was simultaneous expression of PRAB and PRB.
The limited sensitivity of our RT-PCR assay may explain the presence of PRAB and PRB protein in isthmic region samples that were negative for both isoforms in the RT-PCR assay. While the PCR method is very sensitive our agarose gel method of analyzing the PCR products is not. It is therefore possible that very low levels of expression may not have been identified using the RT-PCR method.
The immunohistochemistry results showed that the regulation of PRAB and PRB isoforms in the oviduct smooth muscle cells may be through a different mechanism than the mucosal cells and this may be due to the different functions of the specific cell types within the oviduct. The function of the smooth muscle cells in regulating the transport of gametes and embryos may require different timing to the function of the mucosal cells to facilitate fertilization and early embryo cleavage. The precise local control of the ratio of repressor PRAB and activator PRB expression in each tissue type could lead to different action in these tissues despite exposure to similar concentrations of progesterone.
The results of this study demonstrate that progesterone is likely to function in a different manner in the fimbrial compared to the ampullary region. Consistent among all samples was a relative increase in the proportion of the transcription activator PRB isoform to the transcription repressor PRAB isoform in the fimbrial region. The fimbrial region functions to capture and transport oocytes to the ampullary region where sperm capacitation, oocytesperm binding, fertilization and early embryo cleavage takes place. Progesterone responsive genes are more likely to be activated in the ampullary region of the oviduct than in the fimbrial region due to the change in PRAB to PRB ratio (9, 10) .
CONCLUSION
This study focused on the regulation of PRAB and PRB in mucosal cells as these are the cells that interact directly with gametes and early embryos. Our data provides further evidence to support the hypothesis that P may play a specific role in providing an appropriate environment for sperm capacitation, fertilization and early embryo cleavage in oviduct mucosal cells.
